What is Laser Cancer Therapy?
Laser remedy makes use of an intense, slender beam of mild to cast off or damage most cancers and odd cells that can flip into cancer. Tumor cells take in mild of distinctive wavelengths (or colors) than everyday cells do. So, tumor cells can be focused by using deciding on the ideal wavelength of the laser. Laser remedy is a type of nearby treatment, which potential it treats a unique phase of body. Lasers can additionally be used in different kinds of neighborhood treatment, which includes photodynamic remedy and a therapy that is like hyperthermia, known as laser interstitial thermal therapy, or LITT. Laser remedy is most regularly used to deal with cancers and precancers on the floor of the physique or the lining of interior organs. Laser remedy makes use of a very narrow, targeted beam of mild to reduce or smash most cancers cells. It can be used to reduce out tumors besides destructive different tissue. and Laser remedy is regularly given thru a thin, lighted tube that is put interior the body. Thin fibers at the cease of the tube direct the mild at the most cancers cells. Lasers are additionally used on the skin.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Biolase Inc. (United States), Alma Lasers (Israel), Cutera (United States), IRIDEX Corp. (United States), Valeant (Canada), Coherent, Inc. (United States), Angiodynamics, Inc. (United States), Boston Scientific Corporation (United States), BTL (United States) and Meditech International Inc. (BIOFLEX Laser Therapy) (United States) |
CAGR | % |
The market study is broken down, by Application (Dermatology and Aesthetics, Dental, Ophthalmology, Cardiovascular and Others) and major geographies with country level break-up.
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Laser Cancer Therapy market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Biolase Inc. (United States), Alma Lasers (Israel), Cutera (United States), IRIDEX Corp. (United States), Valeant (Canada), Coherent, Inc. (United States), Angiodynamics, Inc. (United States), Boston Scientific Corporation (United States), BTL (United States) and Meditech International Inc. (BIOFLEX Laser Therapy) (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Baring Private Equity Asia Ltd (Lumenis) (Hong Kong), Biolitec AG UntereViaduktgasse (Austria) and Hologic Inc., (United States).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Laser Cancer Therapy market by Type, Application and Region.
On the basis of geography, the market of Laser Cancer Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Laser Cancer Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Laser Therapy, the sub-segment i.e. Carbon dioxide (CO2) lasers will boost the Laser Cancer Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cancer, the sub-segment i.e. Blood Cancer will boost the Laser Cancer Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In 2021, Amgen's LUMAKRAS (sotorasib) was once authorised with the aid of the U.S. Food and Drug Administration (FDA) for the remedy of person sufferers with KRAS G12C-mutated domestically superior or metastatic non-small cellphone lung most cancers (NSCLC)., , In 2021, Cadila Healthcare launched Trastuzumab Emtansine, one of the first Antibody Drug Conjugate (ADC) biosimilar for treating each early and superior HER2 high-quality breast cancer., and In 2020, IRIDEX Corporation, a producer of ophthalmic laser-based scientific products, launched an upgraded second-generation model of MicroPulse P3 Device to deal with glaucoma, and the enhancements made to the machine is anticipated to appreciably limit intraocular strain appropriate for glaucoma sufferers besides incisions.
Market Trend
- Patient Preference toward LLT
Market Drivers
- Increasing Consumer Preference towards Innovative Laser-Based Technologies
- Growing Prevalence of Diseases like Cataract and Arthritis
Opportunities
- The Increasing Dependence on the Laser Therapy Market Supports Several Industries
Restraints
- Risk of Skin Cancer and Accelerated Skin Aging Among Patients
- High Cost of Surgeries Limits the Growth of the Laser Therapy
Challenges
- Laser Equipment Costs a Lot of Money and Is Bulky Compared With the Usual Surgical Tools Used
- Not Many Doctors and Nurses Are Trained To Use Lasers
- Strict Safety Precautions Must Be Followed In the Operating Room When Lasers Are Used
Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as Biolase Inc. (United States), Alma Lasers (Israel), Cutera (United States), IRIDEX Corp. (United States), Valeant (Canada), Coherent, Inc. (United States), Angiodynamics, Inc. (United States), Boston Scientific Corporation (United States), BTL (United States) and Meditech International Inc. (BIOFLEX Laser Therapy) (United States) etc.
2. Can we have customized study for Laser Cancer Therapy Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of Laser Cancer Therapy Market by 2027?
Analysts at AMA estimates Laser Cancer Therapy Market to reach USD Million by 2027.